Austrian study seeks to eliminate hepatitis by linking patients to care
NCT ID NCT06834178
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in South-East Austria looks at past lab results to find people with hepatitis B, C, or D who may not know they have it. Researchers will invite these individuals to a clinic to discuss treatment options. The goal is to connect them to care and track how many get cured, helping to reduce hepatitis in the region.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help eliminate hepatitis in the region by connecting undiagnosed patients to treatment.
- What could go wrong
- This is an observational study, not testing a new treatment. Success depends on patient participation and existing healthcare resources.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COINFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Internal Medicine, Division of Gastroenterology and Hepatology
RECRUITINGGraz, Styra, 8036, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
- Can a simple roadside test catch liver disease before it turns deadly?
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Hospital care model aims to treat opioid addiction and serious infections together
- Simple blood test aims to spot multiple cancers early